Novel 7-[2-(2-aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]cephalosporanic acid derivatives of the formula: ##STR1## wherein R.sup.1 NH is an amino group which may optionally be protected, R.sup.2 is a halogen atom or a hydroxyl, thiol or amino group which may optionally be substituted; COOR is a carboxyl group which may optionally be esterified, and pharmaceutically acceptable salts thereof, have excellent antimicrobial activity against a broad spectrum of microorganisms including Gram-negative bacteria such as Escherichia coli, Serratia marcescens, Proteus rettgeri, Enterobacter cloacae, Citrobacter freundii. Thus, these compounds may be used as antibacterial agents for therapeutic purposes.
7-[2-(
2-氨基噻唑-4-基)-2-(syn)-甲氧基
亚胺基乙酰胺基]
头孢菌素酸衍
生物的
化学式为:##STR1## 其中,R.sup.1 NH是一种
氨基基团,可以选择性地被保护,R.sup.2是卤素原子或羟基、
硫醇或
氨基基团,可以选择性地被取代;COOR是一种羧基团,可以选择性地被酯化,以及其药学上可接受的盐,对广谱微
生物包括革兰氏阴性菌如大肠杆菌、马赛氏菌、雷特格氏变形杆菌、克雷伯氏菌具有优异的抗微
生物活性。因此,这些化合物可以用作治疗用的抗菌剂。